| Nfe2l2 | affects expression | EXP | | 6480464 | CTD | Paraquat affects the expression of NFE2L2 protein | PMID:31715309 |
| Nfe2l2 | affects localization | EXP | | 6480464 | CTD | Paraquat affects the localization of NFE2L2 protein | PMID:22678742 PMID:32064027 PMID:35707280 |
| Nfe2l2 | decreases expression | EXP | | 6480464 | CTD | Paraquat results in decreased expression of NFE2L2 mRNA; Paraquat results in decreased expression of NFE2L2 protein | PMID:28624451 PMID:35236239 |
| Nfe2l2 | increases expression | EXP | | 6480464 | CTD | Paraquat results in increased expression of NFE2L2 mRNA; Paraquat results in increased expression of NFE2L2 protein | PMID:20095329 PMID:24812154 PMID:25169090 PMID:26598004 PMID:32064027 |
| Nfe2l2 | increases phosphorylation | EXP | | 6480464 | CTD | Paraquat results in increased phosphorylation of NFE2L2 protein | PMID:30112919 |
| Nfe2l2 | increases response to substance | EXP | | 6480464 | CTD | NFE2L2 protein results in increased susceptibility to Paraquat | PMID:22678742 |
| Nfe2l2 | multiple interactions | EXP | | 6480464 | CTD | [Mifepristone co-treated with Paraquat] results in increased expression of NFE2L2 mRNA; [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat promotes the reaction [KEAP1 protein binds to NFE2L2 protein]]; [sodium bisulfide results in increased abundance of Hydrogen Sulfide] promotes the reaction [Paraquat affects the localization of NFE2L2 protein]; [sodium bisulfide results in increased abundance of Hydrogen Sulfide] promotes the reaction [Paraquat results in increased expression of NFE2L2 protein]; Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 mRNA]; Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein]; Estradiol affects the reaction [Paraquat affects the expression of NFE2L2 protein]; ginkgolide C inhibits the reaction [Paraquat affects the localization of NFE2L2 protein]; MIR136 promotes the reaction [Paraquat results in decreased expression of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased activity of CASP3 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased activity of CASP7 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAK1 mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAX mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of CASP12 mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of DDIT3 mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of DDIT3 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of HSPA5 mRNA]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of HSPA5 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of TP53 mRNA]; NFE2L2 protein affects the reaction [[sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in increased cleavage of CASP1 protein]]; NFE2L2 protein affects the reaction [[sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [[sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in decreased expression of SIRT3 protein]]; NFE2L2 protein affects the reaction [Paraquat results in decreased expression of SIRT3 protein]; NFE2L2 protein affects the reaction [Paraquat results in increased cleavage of CASP1 protein]; NFE2L2 protein affects the reaction [Paraquat results in increased expression of NLRP3 protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of RELA protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of TNF protein]; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA]; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [Sirolimus inhibits the reaction [Paraquat results in decreased expression of CDH1 protein]]; NFE2L2 protein promotes the reaction [Sirolimus inhibits the reaction [Paraquat results in increased expression of SNAI1 protein]]; NFE2L2 protein promotes the reaction [Sirolimus inhibits the reaction [Paraquat results in increased expression of VIM protein]]; Paraquat promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of NFE2L2 protein]]; Resveratrol inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; Sirolimus inhibits the reaction [Paraquat results in decreased expression of NFE2L2 mRNA]; Sirolimus inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; Unithiol promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | PMID:20095329 PMID:22678742 PMID:24812154 PMID:25169090 PMID:28624451 PMID:31715309 PMID:32064027 PMID:35236239 PMID:35707280 |
| Nfe2l2 | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | Paraquat affects the expression of NFE2L2 protein | PMID:28428137 |
| Nfe2l2 | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | Paraquat affects the expression of NFE2L2 protein | PMID:28428137 PMID:29071302 |
| Nfe2l2 | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | Paraquat affects the localization of NFE2L2 protein | PMID:30562684 PMID:30571954 |
| Nfe2l2 | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | NFE2L2 protein affects the susceptibility to Paraquat | PMID:29950142 |
| Nfe2l2 | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | Paraquat results in decreased expression of NFE2L2 mRNA; Paraquat results in decreased expression of NFE2L2 protein | PMID:20851755 PMID:24866057 PMID:31385236 |
| Nfe2l2 | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | Paraquat results in decreased expression of NFE2L2 mRNA; Paraquat results in decreased expression of NFE2L2 protein | PMID:17215068 PMID:26758514 PMID:30571954 PMID:30744607 PMID:33838153 |
| Nfe2l2 | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | NFE2L2 protein results in decreased susceptibility to Paraquat | PMID:22493042 |
| Nfe2l2 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | Paraquat results in increased expression of NFE2L2 mRNA; Paraquat results in increased expression of NFE2L2 protein | PMID:22709784 PMID:23546295 PMID:23649336 PMID:24141985 PMID:24561720 PMID:26649146 PMID:35641671 PMID:37507096 |
| Nfe2l2 | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | Paraquat results in increased expression of NFE2L2 mRNA; Paraquat results in increased expression of NFE2L2 protein | PMID:22983789 PMID:25579023 PMID:26708779 PMID:28115273 PMID:29950142 PMID:32540480 |
| Nfe2l2 | increases phosphorylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | Paraquat results in increased phosphorylation of NFE2L2 protein | PMID:27788593 |
| Nfe2l2 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased expression of IL10 protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CYCS mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL10 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF protein]; [naringenin co-treated with Paraquat] results in increased expression of NFE2L2 protein; [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein; [Paraquat co-treated with Ellagic Acid] results in increased expression of NFE2L2 mRNA; [Paraquat co-treated with Quercetin] results in increased expression of NFE2L2 mRNA; [Paraquat co-treated with Quercetin] results in increased localization of NFE2L2 protein; [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein; [Resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Paraquat; [Silymarin co-treated with Paraquat] results in increased expression of NFE2L2 protein; [SIRT6 protein results in decreased susceptibility to Paraquat] inhibits the reaction [NFE2L2 protein binds to HMOX1 enhancer]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein]; CAT protein inhibits the reaction [Paraquat results in decreased expression of NFE2L2 mRNA]; Meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; NFE2L2 mRNA promotes the reaction [Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]]; NFE2L2 protein affects the reaction [ERBB2 protein results in decreased susceptibility to Paraquat]; NFE2L2 protein inhibits the reaction [Paraquat results in decreased expression of GPX4 protein]; NFE2L2 protein inhibits the reaction [Paraquat results in decreased expression of SLC7A11 protein]; NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of IL6 protein]; NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of SQSTM1 protein]; NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of TGFB1 protein]; NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of TNF protein]; NFE2L2 protein promotes the reaction [Paraquat results in increased expression of COL28A1 mRNA]; NFE2L2 protein promotes the reaction [Paraquat results in increased expression of SLC40A1 protein]; NFE2L2 protein promotes the reaction [Paraquat results in increased expression of SQSTM1 protein]; Paraquat promotes the reaction [MIR153 mRNA binds to NFE2L2 3' UTR]; Paraquat promotes the reaction [Plant Extracts affects the localization of NFE2L2 protein]; Paraquat promotes the reaction [Resveratrol results in increased expression of and results in increased activity of NFE2L2 protein]; Paraquat promotes the reaction [Silymarin affects the localization of NFE2L2 protein]; Paraquat results in increased expression of and results in increased activity of NFE2L2 protein; Plant Extracts promotes the reaction [Paraquat results in increased expression of NFE2L2 protein]; Silymarin promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA]; Thioctic Acid promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | PMID:20851755 PMID:22493042 PMID:22709784 PMID:22736252 PMID:22996356 PMID:23546295 PMID:23649336 PMID:24141985 PMID:24561720 PMID:24866057 PMID:25467193 PMID:28428137 PMID:31216030 PMID:33495402 PMID:37507096 |
| Nfe2l2 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | CTD | 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein]; [HFE protein alternative form affects the susceptibility to Paraquat] which affects the expression of NFE2L2; AKT2 protein affects the reaction [Paraquat results in increased expression of NFE2L2 protein]; ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein]; HFE protein alternative form affects the reaction [Paraquat results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [HFE protein alternative form affects the susceptibility to Paraquat]; NFE2L2 protein affects the reaction [Paraquat affects the expression of MIR380 mRNA]; NFE2L2 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [Paraquat results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Paraquat results in increased expression of LAMP2 protein alternative form]; NFE2L2 protein affects the reaction [Paraquat results in increased expression of MIR195 mRNA]; NFE2L2 protein affects the reaction [Paraquat results in increased expression of MIR669B mRNA]; Paraquat affects the expression of and results in decreased stability of NFE2L2 protein; Paraquat inhibits the reaction [NFE2L2 protein binds to MIR380 promoter]; PARK7 gene mutant form affects the reaction [Paraquat affects the expression of NFE2L2 protein]; plant extract, Puerariae Radix inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; resolvin D1 analog inhibits the reaction [Paraquat affects the localization of NFE2L2 protein]; resolvin D1 inhibits the reaction [Paraquat affects the localization of NFE2L2 protein]; resolvin D1 inhibits the reaction [Paraquat results in decreased expression of NFE2L2 mRNA]; rhyncophylline inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; SIRT1 protein inhibits the reaction [Paraquat results in decreased stability of NFE2L2 protein]; tetramethylpyrazine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA]; Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | PMID:17823202 PMID:22983789 PMID:25579023 PMID:26758514 PMID:26935021 PMID:28115273 PMID:28428137 PMID:29071302 PMID:29950142 PMID:30562684 PMID:30571954 PMID:30744607 PMID:31368498 PMID:32540480 PMID:33838153 |
